This is growth stock with strong fundamentals. It's marketed products are:
" H.P. Acthar® Gel (repository corticotropin injection) is currently approved in the U.S. for the treatment of acute exacerbations of multiple sclerosis in adults, and as monotherapy for the treatment of infantile spasms in infants and children under 2 years of age.
Doral® (quazepam tablets, USP) is indicated for the treatment of insomnia"